T F Meyer
Overview
Explore the profile of T F Meyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
5490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eletto D, Mentucci F, Vllahu M, Voli A, Petrella A, Boccellato F, et al.
Open Biol
. 2022 Dec;
12(12):220278.
PMID: 36514982
Chronic infection is the leading cause of intestinal-type adenocarcinoma, as prolonged colonization triggers chronic active gastritis, which may evolve into adenocarcinoma of the intestinal type. In this environment, cytokines play...
2.
Aebischer T, Bumann D, Epple H, Metzger W, Schneider T, Cherepnev G, et al.
Gut
. 2008 Apr;
57(8):1065-72.
PMID: 18417532
Background: Helicobacter pylori remains a global health hazard, and vaccination would be ideal for its control. Natural infection appears not to induce protective immunity. Thus, the feasibility of a vaccine...
3.
Otasevic L, Walduck A, Meyer T, Aebischer T, Hartmann C, Orlic N, et al.
Infection
. 2005 Apr;
33(2):82-5.
PMID: 15827876
Background: Despite intensive research, the etiology of acute anterior uveitis (AAU) remains poorly defined. Infection with gram-negative bacteria such as Yersinia, Salmonella, Shigella, and Chlamydia have already been suggested as...
4.
Metzger W, Mansouri E, Kronawitter M, Diescher S, Soerensen M, HURWITZ R, et al.
Vaccine
. 2004 May;
22(17-18):2273-7.
PMID: 15149786
Orally administered recombinant Salmonella vaccines represent an attractive option for mass vaccination programmes against various infectious diseases. Therefore, it is crucial to gather knowledge about the possible impact of preexisiting...
5.
Jose J, Otto G, Meyer T
Mol Genet Genomics
. 2003 Apr;
269(2):197-204.
PMID: 12720087
An IgA1 protease is produced by the human pathogens Neisseria gonorrhoeae and N. meningitidis but not by related non-pathogenic, commensal, Neisseria species. In this study, the chromosomal iga locus was...
6.
Sabarth N, HURWITZ R, Meyer T, Bumann D
Infect Immun
. 2002 Oct;
70(11):6499-503.
PMID: 12379737
A multiparameter selection of Helicobacter pylori antigens for vaccine development identified 15 candidates, 6 of which are known protective antigens. Two novel antigens with low homology to other organisms (HP0231...
7.
Bumann D, Metzger W, Mansouri E, Palme O, Wendland M, HURWITZ R, et al.
Vaccine
. 2001 Dec;
20(5-6):845-52.
PMID: 11738748
Helicobacter pylori urease was expressed in the common live typhoid vaccine Ty21a yielding Ty21a(pDB1). Nine volunteers received Ty21a(pDB1) and three control volunteers received Ty21a. No serious adverse effects were observed...
8.
Backert S, Moese S, Selbach M, Brinkmann V, Meyer T
Mol Microbiol
. 2001 Nov;
42(3):631-44.
PMID: 11722731
Helicobacter pylori colonizes the human stomach and is the causative agent of a variety of gastric diseases. After bacterial attachment, the H. pylori CagA protein is translocated into gastric epithelial...
9.
Rajalingam K, Muller A, Meyer T, Szczepek A, Rudel T
Infect Immun
. 2001 Nov;
69(12):7880-8.
PMID: 11705971
The obligate intracellular pathogen Chlamydophila pneumoniae (Chlamydia pneumoniae) initiates infections in humans via the mucosal epithelia of the respiratory tract. Here, we report that epithelial cells infected with C. pneumoniae...
10.
Moese S, Selbach M, Zimny-Arndt U, Jungblut P, Meyer T, Backert S
Proteomics
. 2001 Oct;
1(4):618-29.
PMID: 11681214
Helicobacter pylori is a very common bacterial pathogen that causes gastric disease by inducing the infiltration of immune cells as an initial event. Virulent H. pylori strains express a type...